Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

休市中 10-02 16:00:00 EDT

163.75

+0.58

+0.36%

盘后163.75

+0.000.00%

19:30 EDT

最高168.08	最低163.01	成交量74.28万
今开167.57	昨收163.17	日振幅3.11%
总市值96.59亿	流通市值92.42亿	总股本5,898万
成交额1.22亿	换手率1.32%	流通股本5,644万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":163.75,"timestamp":1790971200000,"preClose":163.17,"halted":0,"volume":742806,"hourTrading":{"tag":"盘后","latestPrice":163.75,"preClose":163.75,"latestTime":"19:30 EDT","volume":93937,"amount":15381523.8335,"timestamp":1790983803825,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0035545749831464887,"floatShares":56438109,"shares":58983937,"eps":-3.245648,"marketStatus":"休市中","change":0.58,"latestTime":"10-02 16:00:00 EDT","open":167.57,"high":168.08,"low":163.01,"amount":122342651.45622,"amplitude":0.031072,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.245648,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NYSE","adjPreClose":163.17,"preHourTrading":{"tag":"盘前","latestPrice":168,"preClose":163.17,"latestTime":"09:28 EDT","volume":1219,"amount":200349.31793,"timestamp":1790947737874,"change":4.83,"changeRate":0.029601,"amplitude":0.076607},"postHourTrading":{"tag":"盘后","latestPrice":163.75,"preClose":163.75,"latestTime":"19:30 EDT","volume":93937,"amount":15381523.8335,"timestamp":1790983803825,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8038206493488884,"impliedVol":0.6522,"impliedVolPercentile":0.7769},"requestUrl":"/m/hq/s/GKOS/wiki","defaultTab":"wiki","newsList":[{"id":"1177498121","title":"异动解读｜Glaukos Corp盘中上涨5.46%，Q2业绩大超预期叠加多家机构上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1177498121","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177498121?lang=zh_cn&edition=full","pubTime":"2026-08-08 03:57","pubTimestamp":1786132625,"startTime":"0","endTime":"0","summary":"8月8日，Glaukos Corp盘中上涨5.46%，报180.25美元/股，成交额1.05亿美元。消息面上，公司此前发布的Q2财报大幅超出市场预期：调整后每股亏损收窄至0.14美元，优于市场预期的亏损0.22美元；营收达1.856亿美元，较预期的1.509亿美元高出约23%。同时，公司将全年营收指引上调至6.8亿至7亿美元，远高于市场此前预估的6.3亿美元。财报发布后，多家机构密集上调目标价：Needham将目标价从150美元大幅调升至201美元，HC Wainwright上调至195美元，均维持买入评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172806983","title":"异动解读｜Glaukos Corp盘中上涨5.21%，二季度营收与全年指引双双大超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1172806983","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172806983?lang=zh_cn&edition=full","pubTime":"2026-07-31 00:22","pubTimestamp":1785428535,"startTime":"0","endTime":"0","summary":"7月30日，Glaukos Corp盘中上涨5.21%，报169.765美元/股，成交额2.23亿美元。消息面上，公司于盘后发布第二季度财报，营收与全年指引均大幅超出市场预期，成为推动股价走强的核心催化剂。同时，公司将全年销售指引大幅上调至6.8亿至7.0亿美元，远超FactSet此前6.3亿美元的一致预期。这已是公司连续第二个季度营收显著超预期，延续高增态势。此外，Needham将目标价从150美元大幅上调至201美元并维持买入评级，进一步提振市场情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141459642","title":"异动解读｜Glaukos Corp盘前上涨9.49%，二季度营收与全年指引双双大超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1141459642","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141459642?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:22","pubTimestamp":1785403358,"startTime":"0","endTime":"0","summary":"7月30日，Glaukos Corp盘前上涨9.49%，报177.0美元/股。消息面上，公司于盘后发布第二季度财报，营收与全年指引均大幅超出市场预期，成为股价走强的核心催化剂。此外，公司将全年销售指引大幅上调至6.8亿至7.0亿美元，远超FactSet此前6.3亿美元的一致预期。这已是公司连续第二个季度营收显著超预期，延续高增态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147377509","title":"异动解读 | 二季度营收与指引双超预期，Glaukos Corp夜盘大涨6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147377509","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147377509?lang=zh_cn&edition=full","pubTime":"2026-07-30 09:36","pubTimestamp":1785375397,"startTime":"0","endTime":"0","summary":"Glaukos Corp夜盘交易时段股价大涨6.33%，引发市场关注。消息面上，公司于盘后发布了第二季度财报，业绩表现远超市场预期。数据显示，公司第二季度销售额达到1.856亿美元，较市场普遍预期的1.509亿美元高出约23%；调整后每股亏损0.14美元，优于预期的亏损0.22美元，亏损幅度同比也明显收窄。此外，公司还将全年销售指引上调至6.8亿至7.0亿美元，大幅超出FactSet此前6.3亿美元的一致预期。营收与指引双双亮眼，成为推动股价在夜盘持续走强的核心催化剂。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129491890","title":"异动解读｜Glaukos Corp夜盘上涨6.33%，二季度营收与指引双双大超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1129491890","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129491890?lang=zh_cn&edition=full","pubTime":"2026-07-30 09:34","pubTimestamp":1785375277,"startTime":"0","endTime":"0","summary":"7月30日，Glaukos Corp夜盘上涨6.33%，报171.9美元/股。消息面上，公司于盘后发布第二季度财报，营收与全年指引均大幅超出市场预期，成为推动股价走高的核心催化剂。此外，公司将全年销售指引上调至6.8亿至7.0亿美元区间，远超FactSet此前6.3亿美元的一致预期。这已是公司连续第二个季度营收大幅超预期，Q1销售额1.506亿美元同样显著好于1.37亿美元的预期，延续高增态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Glaukos Corp夜盘上涨6.33%，二季度营收与指引双双大超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124010311","title":"异动解读 | 二季度营收远超预期，Glaukos Corp盘后大涨9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124010311","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124010311?lang=zh_cn&edition=full","pubTime":"2026-07-30 04:50","pubTimestamp":1785358225,"startTime":"0","endTime":"0","summary":"Glaukos Corp今日盘后股价大涨9.77%，引发市场广泛关注。消息面上，公司于盘后发布了第二季度财报，数据显示销售额达到1.856亿美元，显著高于市场普遍预期的1.509亿美元，成为推动盘后股价飙升的核心催化剂。尽管公司本季度录得净亏损1840万美元，但营收端的强劲表现极大地提振了投资者信心。管线里程碑与财报超预期形成共振，共同推动盘后股价大幅走高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168687286","title":"Glaukos第二季度销售额达1.856亿美元，远超市场预期的1.509亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168687286","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168687286?lang=zh_cn&edition=full","pubTime":"2026-07-30 04:21","pubTimestamp":1785356496,"startTime":"0","endTime":"0","summary":"Glaukos公布第二季度财报，净亏损1840万美元。但与此同时，公司销售额表现亮眼，达到1.856亿美元，显著高于市场普遍预期的1.509亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","LU1878469433.USD","BK4548","BK4082","GKOS","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136642919","title":"异动解读｜Glaukos Corp盘后上涨5.05%，管线里程碑与财报催化共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1136642919","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136642919?lang=zh_cn&edition=full","pubTime":"2026-07-30 04:06","pubTimestamp":1785355619,"startTime":"0","endTime":"0","summary":"7月29日，Glaukos Corp盘后上涨5.05%，报167.0美元/股，成交额236.89万美元。机构层面，Truist将目标价从160美元上调至180美元并维持买入评级，Needham亦多次上调目标价；尽管瑞银近日将评级下调至中性，但整体市场情绪偏多，FactSet统计均值目标价为163.85美元。管线进展与财报催化形成共振，推动盘后进一步走高。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198278176","title":"异动解读｜Glaukos Corp盘中上涨5.07%，管线里程碑叠加财报预期提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1198278176","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198278176?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:45","pubTimestamp":1785347131,"startTime":"0","endTime":"0","summary":"7月29日，Glaukos Corp盘中上涨5.07%，报158.775美元/股，成交额1.95亿美元。同时，市场对公司即将发布的季度财报持乐观预期，一致预期本季度营收约1.51亿美元，同比增长30.68%，延续高增态势。尽管瑞银近日将公司评级从买入下调至中性，但Truist等多家机构维持买入评级并上调目标价，整体市场情绪偏多。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176482715","title":"Glaukos宣布完成Preserflo™微型引流器510(k)关键性研究患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1176482715","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176482715?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:04","pubTimestamp":1785150246,"startTime":"0","endTime":"0","summary":"Glaukos公司正式宣告，其针对Preserflo™微型引流器的510(k)关键性研究已完成患者入组工作。这一里程碑式的进展，标志着该产品上市进程迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4082","LU2065731478.USD","IE0009354923.USD","BK4548","GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101767534","title":"财报前瞻｜Glaukos Corp本季度营收预计增30.68%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1101767534","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101767534?lang=zh_cn&edition=full","pubTime":"2026-07-22 12:13","pubTimestamp":1784693604,"startTime":"0","endTime":"0","summary":"Glaukos Corp将于2026年07月29日发布财报，市场关注收入增速与亏损收窄节奏。市场一致预期Glaukos Corp本季度收入约1.51亿美元，同比增长30.68%；调整后每股收益约-0.22美元，同比改善15.63%。市场预计本季度公司收入约1.51亿美元、同比增长30.68%，延续上季41.16%的高增节奏，核心来源仍然是青光眼相关产品的放量贡献。近期机构观点整体偏多，目标价普遍上调并维持买入评级，显示看多意见占据明显多数。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Glaukos Corp本季度营收预计增30.68%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109471401","title":"Glaukos宣布完成针对蠕形螨睑缘炎药物Glk-321的二期临床试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1109471401","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109471401?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:02","pubTimestamp":1782385354,"startTime":"0","endTime":"0","summary":"Glaukos公司已顺利完成其候选药物Glk-321针对蠕形螨睑缘炎适应症的第二阶段临床试验的患者入组工作。这一进展标志着该疗法在临床开发路径上迈出了关键一步，为后续评估其有效性与安全性奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","GKOS","BK4548","BK4082","LU2065731478.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135372932","title":"异动解读 | 券商上调目标价，Glaukos Corp盘中大涨24.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135372932","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135372932?lang=zh_cn&edition=full","pubTime":"2026-05-01 02:51","pubTimestamp":1777575110,"startTime":"0","endTime":"0","summary":"眼科医疗公司Glaukos Corp（股票代码：GKOS）今日盘中股价大幅上涨24.02%，表现异常强劲，成为市场关注的焦点。消息面上，此次股价飙升主要受到多家华尔街券商上调其目标股价的推动。根据相关研究报告，BTIG将Glaukos Corp的目标价从131美元上调至141美元，摩根大通则将目标价从120美元上调至140美元。分析师对公司未来业绩和增长潜力的积极展望，显著提振了投资者的信心，成为推动股价上涨的核心动力。目标价的上调通常反映了机构对公司基本面、行业前景或战略发展的乐观判断，此类正面评级调整往往会直接吸引买盘，从而引发股价的显著波动。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102070876","title":"异动解读 | 券商上调目标价，Glaukos Corp盘前大涨14.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102070876","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102070876?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:11","pubTimestamp":1777551102,"startTime":"0","endTime":"0","summary":"眼科医疗公司Glaukos Corp（股票代码：GKOS）今日盘前股价大幅上涨14.68%，表现强劲。消息面上，多家华尔街券商在最新研究报告中上调了该公司的目标股价。其中，BTIG将目标价从131美元上调至141美元，摩根大通则将目标价从120美元上调至140美元。分析师对公司的积极展望，提振了市场信心，成为推动股价上涨的主要动力。目标价上调通常反映了分析师对公司未来业绩、增长潜力或行业前景的乐观预期，此类消息往往能直接影响投资者情绪和交易行为，从而引发股价的显著波动。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107761972","title":"财报前瞻｜Glaukos Corp本季度营收预计增33.57%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1107761972","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107761972?lang=zh_cn&edition=full","pubTime":"2026-04-22 14:31","pubTimestamp":1776839512,"startTime":"0","endTime":"0","summary":"Glaukos Corp将于2026年04月29日发布最新季度财报，市场关注核心眼科器械与药物管线的放量与利润修复节奏。市场一致预期本季度Glaukos Corp营收为1.37亿美元，同比增33.57%；调整后每股收益为-0.27美元，同比改善21.52%；EBIT为-1,734.58万美元，同比改善14.13%。近期覆盖Glaukos Corp的多家机构观点以正面为主，占比更高的一方强调收入高增与盈利拐点的可见度提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Glaukos Corp本季度营收预计增33.57%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518322289","title":"Glaukos Corporation跌4.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518322289?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613579,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Glaukos Corporation股票出现波动，股价急速跳水4.08%。截至发稿，该股报99.94美元/股，成交量8598股，换手率0.02%，振幅1.40%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.62%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","LU1878469433.USD","BK4082","LU2065731478.USD","GKOS","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517319455","title":"Glaukos Corporation盘中异动 下午盘急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517319455?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:26","pubTimestamp":1741285610,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时26分，Glaukos Corporation股票出现波动，股价快速跳水5.14%。截至发稿，该股报106.36美元/股，成交量29.6086万股，换手率0.52%，振幅3.26%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为2.00%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","LU1878469433.USD","BK4548","IE0009354923.USD","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516373576","title":"Glaukos Corporation盘中异动 早盘急速下跌5.18%报113.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516373576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516373576?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014342,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Glaukos Corporation股票出现波动，股价大幅下挫5.18%。截至发稿，该股报113.80美元/股，成交量10.7329万股，换手率0.19%，振幅4.82%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.59%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","LU2065731478.USD","LU1878469433.USD","GKOS","BK4548","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015888","title":"Glaukos Corporation盘中异动 早盘股价大跌5.20%报117.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015888?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:11","pubTimestamp":1740496279,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时11分，Glaukos Corporation股票出现异动，股价急速下跌5.20%。截至发稿，该股报117.78美元/股，成交量19.1002万股，换手率0.34%，振幅5.88%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.41%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4082","LU2065731478.USD","GKOS","BK4548","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513375613","title":"Glaukos Corporation2024财年实现净利润-1.46亿美元，同比减少8.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513375613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513375613?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326467,"startTime":"0","endTime":"0","summary":"2月24日，Glaukos Corporation公布财报，公告显示公司2024财年净利润为-1.46亿美元，同比减少8.15%；其中营业收入为3.83亿美元，同比增加21.59%，每股基本收益为-2.77美元。从资产负债表来看，Glaukos Corporation总负债2.08亿美元，其中短期债务--，资产负债比为4.69，流动比率为0.06。机构评级：截至2025年2月24日，当前有13家机构对Glaukos Corporation目标价做出预测，其中目标均价为168.62美元，其中最低目标价为120.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":0.0604},{"period":"1month","weight":-0.0879},{"period":"3month","weight":0.1039},{"period":"6month","weight":0.4521},{"period":"1year","weight":0.9381},{"period":"ytd","weight":0.4503}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司，专注于开发新型无滴剂疗法，并将相关产品商业化，用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术（MIGS）作为传统青光眼治疗模式的替代方案，并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法，用于治疗罕见的角膜疾病圆锥角膜，该疗法于2016年获得美国食品和药物管理局（FDA）的批准。他们正在开发一系列平台，以支持正在进行的制药和医疗器械创新。","yearOnYearQuotes":[{"month":1,"riseRate":0.909091,"avgChangeRate":0.08374},{"month":2,"riseRate":0.636364,"avgChangeRate":-0.005569},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.03024},{"month":4,"riseRate":0.545455,"avgChangeRate":0.040364},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.003117},{"month":6,"riseRate":0.909091,"avgChangeRate":0.132641},{"month":7,"riseRate":0.666667,"avgChangeRate":0.032986},{"month":8,"riseRate":0.5,"avgChangeRate":0.051626},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.036372},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014387},{"month":11,"riseRate":0.545455,"avgChangeRate":0.030479},{"month":12,"riseRate":0.545455,"avgChangeRate":0.013516}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}